Archives of Cardiovascular Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

JESFC 2024: Citius, Fortius, Altius! Faster, higher, stronger!
Arch Cardiovasc Dis. 2024 Jan;117(1S):S1-S2. doi: 10.1016/j.acvd.2023.12.001.NO ABSTRACTPMID:38143089 | DOI:10.1016/j.acvd.2023.12.001 (Source: Archives of Cardiovascular Diseases)
Source: Archives of Cardiovascular Diseases - December 24, 2023 Category: Cardiology Authors: Victor Aboyans Anne Bernard Ariel Cohen Bernard Iung Christophe Leclercq Source Type: research

Management of cancer-associated thromboembolism: Introduction
Arch Cardiovasc Dis. 2024 Jan;117(1):3-5. doi: 10.1016/j.acvd.2023.11.002. Epub 2023 Nov 21.NO ABSTRACTPMID:38087662 | DOI:10.1016/j.acvd.2023.11.002 (Source: Archives of Cardiovascular Diseases)
Source: Archives of Cardiovascular Diseases - December 13, 2023 Category: Cardiology Authors: Isabelle Mah é Olivier Sanchez Patrick Mismetti Source Type: research

Paramedics and remote monitoring of cardiac implantable electronic devices in France
Arch Cardiovasc Dis. 2023 Nov 11:S1875-2136(23)00491-6. doi: 10.1016/j.acvd.2023.10.296. Online ahead of print.NO ABSTRACTPMID:38087663 | DOI:10.1016/j.acvd.2023.10.296 (Source: Archives of Cardiovascular Diseases)
Source: Archives of Cardiovascular Diseases - December 13, 2023 Category: Cardiology Authors: Carole Mette Diane Prost Julien Baud Jerome Taieb Eloi Marijon Olivier Piot Source Type: research

Management of venous thromboembolic disease in patients with malignant brain tumours
This article addresses the management of venous thromboembolism in patients with malignant brain tumours, including both primary and secondary (metastatic) tumours. The available data on patients on venous thromboembolism recurrence and bleeding risks in patients with brain tumours is limited, since these patients have been excluded from most randomised, interventional, head-to-head, clinical trials comparing low molecular weight heparins to vitamin K antagonists or to direct oral Factor Xa inhibitors. More information is available from retrospective observational studies, which however were generally small, and carried a ...
Source: Archives of Cardiovascular Diseases - December 13, 2023 Category: Cardiology Authors: Isabelle Mah é Corinne Fr ère Gilles Pernod Olivier Sanchez Ahmed Id Baih INNOVTE CAT Working Group Source Type: research